Frontiers | Past, Present, and Future of Rituximab—The World's First Oncology Monoclonal Antibody Therapy
The proposed mechanisms of action for rituximab, a chimeric monoclonal... | Download Scientific Diagram
Structure of CD20 in complex with the therapeutic monoclonal antibody rituximab | Science
Fungal infections following treatment with monoclonal antibodies and other immunomodulatory therapies | Revista Iberoamericana de Micología
Drug Insight: the mechanism of action of rituximab in autoimmune disease—the immune complex decoy hypothesis | Nature Reviews Rheumatology
Safety and efficacy of rituximab in systemic sclerosis (DESIRES): a double-blind, investigator-initiated, randomised, placebo-controlled trial - The Lancet Rheumatology
Rituximab therapy in autoimmune pulmonary alveolar proteinosis | European Respiratory Society
Anti-CD20 Antibody Therapy for B-Cell Lymphomas | NEJM
Far- and near-UV CD spectra of (a) Rituximab and (b) Etanercept... | Download Scientific Diagram
CDCN on Twitter: "In the next installment of this series on CD drugs, Rituximab. Learn more about this treatment that is highly effective in treating our HHV8 + MCD patients! https://t.co/QlVJWxAviA https://t.co/I3TJneEQg9" /
Drug Repurposing for CD - CDCN
B-lymphocyte Antigen CD20 Epitope Peptide Fragment, Bound To Rituximab (Fab Fragment). Indications for Rituximab Include Leukemia Stock Illustration - Illustration of autoimmune, pdb2osl: 188464521
B-lymphocyte Antigen CD20 Epitope Peptide Fragment, Bound To Rituximab (Fab Fragment). Indications for Rituximab Include Leukemia Stock Illustration - Illustration of arthritis, pemphigus: 188464555
Rituximab, an Anti‐CD20 Monoclonal Antibody: History and Mechanism of Action - Pescovitz - 2006 - American Journal of Transplantation - Wiley Online Library
An analysis of Rituximab dose reduction & CD 19 monitoring
Novel HDAC inhibitor Chidamide synergizes with Rituximab to inhibit diffuse large B-cell lymphoma tumour growth by upregulating CD20 | Cell Death & Disease
Rituximab - Altmeyers Encyclopedia - Department Internal medicine
anti-CD20 (Rituximab) - ACE Biolabs Antibody │ Chemical │ Enzyme
Rituximab Monitoring
Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance | Oncogene
Frontiers | Implications of rituximab pharmacokinetic and pharmacodynamic alterations in various immune-mediated glomerulopathies and potential anti-CD20 therapy alternatives
Rituximab - Wikipedia
Higher order structure analyzed by CD, FT-IR and DSC for CT-P10,... | Download Scientific Diagram
